Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

[Brittle bone disease type III in neonates--own experience].

Jakubowska-Pietkiewicz E, Rusińska A, Michałus I, Chlebna-Sokół D.

Przegl Lek. 2012;69(4):139-42. Polish.

PMID:
23029707
2.

Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: relationship to bone parameters.

Edouard T, Husseini A, Glorieux FH, Rauch F.

J Clin Endocrinol Metab. 2012 Apr;97(4):1243-9. doi: 10.1210/jc.2011-3015.

PMID:
22319032
3.

Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.

Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD.

Calcif Tissue Int. 2003 Dec;73(6):520-30.

PMID:
12958693
5.

Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation.

Dolgos S, Hartmann A, Bønsnes S, Isaksen GA, Godang K, Ueland T, Pfeffer P, Bollerslev J.

Scand J Clin Lab Invest. 2009;69(2):161-7. doi: 10.1080/00365510802449634.

PMID:
18972258
6.

Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.

Tangpricha V, Luo M, Fernández-Estívariz C, Gu LH, Bazargan N, Klapproth JM, Sitaraman SV, Galloway JR, Leader LM, Ziegler TR.

JPEN J Parenter Enteral Nutr. 2006 Nov-Dec;30(6):480-6.

PMID:
17047171
7.

Do patients with osteogenesis imperfecta need individualized nutritional support?

Chagas CE, Roque JP, Santarosa Emo Peters B, Lazaretti-Castro M, Martini LA.

Nutrition. 2012 Feb;28(2):138-42. doi: 10.1016/j.nut.2011.04.003.

PMID:
21795023
8.

Impact of alendronate on quality of life in children with osteogenesis imperfecta.

Seikaly MG, Kopanati S, Salhab N, Waber P, Patterson D, Browne R, Herring JA.

J Pediatr Orthop. 2005 Nov-Dec;25(6):786-91.

PMID:
16294137
9.

Biochemical markers as predictors of rates of bone loss after menopause.

Rogers A, Hannon RA, Eastell R.

J Bone Miner Res. 2000 Jul;15(7):1398-404.

10.

Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.

Antoniazzi F, Bertoldo F, Mottes M, Valli M, Sirpresi S, Zamboni G, Valentini R, Tató L.

J Pediatr. 1996 Sep;129(3):432-9.

PMID:
8804334
11.

Bone mineral density and metabolism in familial dysautonomia.

Maayan C, Bar-On E, Foldes AJ, Gesundheit B, Pollak RD.

Osteoporos Int. 2002 May;13(5):429-33.

PMID:
12086355
12.

[Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus].

Becker A, Fischer R, Schneider M.

Z Rheumatol. 2001 Oct;60(5):352-8. German.

PMID:
11759235
13.

Bone turnover markers in patients with osteogenesis imperfecta.

Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S.

Bone. 2004 Jun;34(6):1013-6.

PMID:
15193547
14.

Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.

Garnero P, Schott AM, Prockop D, Chevrel G.

Bone. 2009 Mar;44(3):461-6. doi: 10.1016/j.bone.2008.11.006.

PMID:
19071236
15.
16.

Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women.

Volpe SL, Leung MM, Giordano H.

Nutr Res. 2008 Sep;28(9):577-82. doi: 10.1016/j.nutres.2008.06.006.

PMID:
19083462
17.

A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.

van der Sluis IM, Hop WC, van Leeuwen JP, Pols HA, de Muinck Keizer-Schrama SM.

Horm Res. 2002;57(5-6):170-9.

PMID:
12053089
18.

Biochemical bone markers compared with bone density measurement by dual energy X-ray absorptiometry.

Lotz J, Steeger D, Hafner G, Ehrenthal W, Heine J, Prellwitz W.

Calcif Tissue Int. 1995 Oct;57(4):253-7.

PMID:
8673861
19.

Serum markers of bone turnover in children and adolescents with classic galactosemia.

Gajewska J, Ambroszkiewicz J, Radomyska B, Chełchowska M, Ołtarzewski M, Laskowska-Klita T, Milanowski A.

Adv Med Sci. 2008;53(2):214-20. doi: 10.2478/v10039-008-0026-8.

PMID:
18650146
20.

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.

J Bone Miner Res. 1996 Mar;11(3):337-49.

PMID:
8852944
Items per page

Supplemental Content

Support Center